Questions about Neurodegenerative diseases
Can natural compounds like oridonin help stop inflammation in Neurodegenerative Disorders?
Natural compounds like oridonin show promise in stopping inflammation by targeting specific immune pathways, but more research is needed to confirm their use for neurodegenerative disorders.
Full answer →All Neurodegenerative diseases Articles
- Curcumin as a theranostics agent: intrinsic fluorescence and protein affinity offer dual diagnostic and therapeutic potential
- Luteolin suppresses neuroinflammation by modulating microglial activation and antioxidant defenses
- NINJ1 targeting shows potential for multiple sclerosis and other neurological conditions but faces significant knowledge gaps
- Narrative review discusses SECTM1 for cancer, cardiovascular disorders, and neurodegenerative diseases without reported outcomes or safety data
- Narrative review explores bromelain's potential across multiple chronic diseases
- Narrative review discusses PROTACs for oncology, immune modulation, and neurodegenerative diseases with noted limitations
- Narrative review discusses neurodegenerative diseases without reporting specific interventions or outcomes
- Global research on olfactory dysfunction mechanisms shows rising publication trends and key molecular pathways
- Narrative review outlines sialidase biology roadmap for genetic syndromes and inflammatory disorders
- Systematic review of AI applications for protein misfolding diseases
- Systematic review synthesizes Rhaponticum species chemistry, traditional uses, and research gaps across multiple conditions
- Narrative review explores cytoskeleton-mediated autophagy regulation in neurodegeneration and aging
- Disability benefit take-up varied by cause of death and geography in England and Wales
- Natural and synthetic compounds suppress inflammasome activation in NLRP3-driven pathologies
- Bioactive compounds and physical exercise may modulate hippocampal neurogenesis and cognitive resilience in aging and neurodegenerative disorders
- Greater cognitive variability in NSD Stage 2 predicts progression to advanced stages in observational study
- Systematic review suggests omega-3 deficiency may be modifiable risk factor for mental disorders